Enveric Biosciences, Inc. (ENVB) NASDAQ
2.26
-0.04(-1.74%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.22M |
| Enterprise Value | -3.46M |
| P/E Ratio | -0.42 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.67 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.49 |
| Return On Equity | -2.21 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -200,858 |
| EBITDA | -8.57M |
| Net Income | -12.13M |
| Diluted EPS | -36.24 |
Balance Sheet
| Total Cash | 4.91M |
| Total Cash/Share | 3.25 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.67 |
| Book Value Per Share | 3.35 |
Price History
| 52-Week Change | -84.69 |
| 52-Week High | 17.64 |
| 52-Week Low | 1.71 |
| Moving Average 50 Days | 2.66 |
| Moving Average 200 Days | 5.44 |
Statistics
| Average Volume | 3.8M |
| Shares Outstanding | 597,012 |
| % Held by Institutions | 3.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | October 28, 2025 |
